DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
- 31 December 2011
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 11 (12), 916-924
- https://doi.org/10.1016/s1473-3099(11)70240-7
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutininProceedings of the National Academy of Sciences of the United States of America, 2011
- Wide Prevalence of Heterosubtypic Broadly Neutralizing Human Anti-Influenza A AntibodiesClinical Infectious Diseases, 2011
- A Phase 1/2 Study of a Multiclade HIV‐1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV‐Uninfected East Africans (RV 172)The Journal of Infectious Diseases, 2010
- Structural and functional bases for broad-spectrum neutralization of avian and human influenza A virusesNature Structural & Molecular Biology, 2009
- A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trialVaccine, 2008
- Heterologous HA DNA vaccine prime—inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza virusesVaccine, 2008
- Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategiesProceedings of the National Academy of Sciences of the United States of America, 2008
- A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical TrialThe Journal of Infectious Diseases, 2007
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 DNA Candidate VaccineThe Journal of Infectious Diseases, 2006
- Phase 1 Safety and Immunogenicity Evaluation of a Multiclade HIV‐1 Candidate Vaccine Delivered by a Replication‐Defective Recombinant Adenovirus VectorThe Journal of Infectious Diseases, 2006